title: Brk is coamplified with ErbB2 to promote proliferation in breast cancer.
abstract: Amplification of the receptor tyrosine kinase ErbB2 is frequently observed in breast cancer. Amplification of erbB2 is also associated with multiple genomic gains and losses; however, the importance of these associated changes is largely unknown. We demonstrate that Brk, a cytoplasmic tyrosine kinase, is coamplified and coexpressed with ErbB2 in human breast cancers. ErbB2 interacts with Brk and increases its intrinsic kinase activity. Expression of Brk enhances the ErbB2-induced activation of Ras/MAPK signaling and cyclin E/cdk2 activity to induce cell proliferation of mammary 3-dimensional acini in culture. In a murine model of breast cancer, expression of Brk was found to shorten the latency of ErbB2-induced tumors by promoting cell proliferation, with no effect on protection from apoptosis. Furthermore, overexpression of Brk conferred resistance to the ability of Lapatinib, an ErbB2 kinase inhibitor, to inhibit ErbB2-induced proliferation. Thus, we identified Brk as a drug target for ErbB2-positive cancers.
authors: Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA.
authors: Bin
authors: B
authors: Xiang
authors: Kiranam
authors: K
authors: Chatti
authors: Haoqun
authors: H
authors: Qiu
authors: B
authors: B
authors: Lakshmi
authors: Alexander
authors: A
authors: Krasnitz
authors: Jim
authors: J
authors: Hicks
authors: Min
authors: M
authors: Yu
authors: W Todd
authors: WT
authors: Miller
authors: Senthil K
authors: SK
authors: Muthuswamy
mesh_terms: D000818:Animals; D001706:Biopsy; D001943:Breast Neoplasms / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D051357:Cyclin-Dependent Kinase 2 / Q000032:analysis / Q000378:metabolism; D005260:Female; D005784:Gene Amplification / Q000502:physiology*; D020869:Gene Expression Profiling; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D051379:Mice; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics* / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D019061:src-Family Kinases / Q000235:genetics / Q000502:physiology*
chemical_list: D051357:Cyclin-Dependent Kinase 2; D009363:Neoplasm Proteins; D011505:Protein-Tyrosine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases; D019061:src-Family Kinases; C088375:PTK6 protein, human; C000598269:Ptk6 protein, mouse; C495894:CDK2 protein, human